Blog Category

CMT Type – CMT1A

Total posts in Category: 15

Pharnext raises € 7.7 million in a private placement

Pharnext SA (FR0011191287 – ALPHA) (the “Company”), a biopharmaceutical company pioneering a new approach to developing innovative drug combinations based on its PLEOTHERAPY artificial intelligence platform harnessing big genomics data and network pharmacology, today announced a capital raise of circa € 7.7 million by way of issuance of 1,799,061 new ordinary shares (the “New Shares”) with one warrant attached each (together with the New Shares, the “ABSA”).

Hot Off the Press – Potential Treatment for CMT1A

Two recent publications from Pharnext describe a novel synergistic combination of 3 drugs (baclofen, naltrexone and sorbitol) and its effect on CMT1A both in the lab and in a phase II clinical trial. These 3 drugs already approved but for unrelated conditions, are combined at new optimal lower doses and under a new formulation. This novel potential therapeutic is called PXT-3003.

Archives

Categories

Advocacy (7)
Awareness (30)
Centers of Excellence (12)
CMT Summit (50)
CMT Update (74)
CMT-Connect (30)
CMT-Connect Webinars (8)
Webinars – Accessible Travel (3)
Webinars – Adaptive Driving (2)
Webinars – Bracing (2)
Webinars – Breathing (1)
Webinars – Canine Companions (1)
Webinars – Cannabis (2)
Webinars – Dating and Relationships (3)
Webinars – Family Planning (1)
Webinars – FEATURED (6)
Webinars – Genetic Testing (2)
Webinars – Home Accessibility (2)
Webinars – Inclusive Employment (3)
Webinars – Inspire Community (1)
Webinars – Legal Rights and Benefits (3)
Webinars – Nutrition (2)
Webinars – Pain (4)
Webinars – PT and Exercise (9)
Webinars – Research and Clinical Trials (6)
Webinars – School and College (4)
Webinars – Surgery (2)
Webinars – Telemedicine (1)
Webinars – UPCOMING (1)
Webinars- Emotional and Mental Health (5)
Faces of CMT (0)
Faces of CMT – Addie (2)
Faces of CMT – Bernadette (9)
Faces of CMT – CMT4A (7)
Faces of CMT – Grace (18)
Faces of CMT – HELP Fund (8)
Faces of CMT – HNPP Fund (3)
Faces of CMT – James (1)
Faces of CMT – Jaxson (5)
Faces of CMT – Zach (17)
Featured (15)
GRIN Patient Registry (15)
HNF Team (9)
Living with CMT (66)
Medical professionals (2)
Movement Is Medicine (16)
Optic Hereditary Neuropathy (5)
Our Impact (0)
Clinical Trials (11)
PFDD (1)
PFDD Meeting 28SEP2018 (5)
Past Events (35)
Patience Resources (0)
Accessible Travel (4)
Bracing (13)
Breathing (3)
Canine Companions (5)
Cannabis (5)
Caregivers (3)
Dating and Relationships (7)
Emotional and Mental Health (5)
Family Planning (1)
Genetic Testing (6)
Home Accessibility (2)
Inclusive Employment (3)
Inspire Community (5)
Legal Rights and Benefits (8)
Neurotoxic Drugs (4)
Newly Diagnosed (3)
Nutrition (2)
Occupational Thearpy (2)
Pain (7)
Podiatry (4)
PT and Exercise (27)
Research and Critical Trials (7)
School & College (6)
Surgery (10)
Telemedicine (1)
Tips and Hacks (2)
Pediatrics & CMT (4)
Research (76)
School Outreach Program and Team CMT Kids (1)
Special Events (0)
Bike New York (17)
Other Events (3)
Spin-a-thon (7)
TCS New York City Marathon (7)
Team CMT Members (57)
The CMT Genie (1)
TRIAD (19)
TRIAD – Clinical Trial Readiness (0)
Vitaccess (1)
TRIAD – Research Gifts (0)
University of Helsinki (2)
Veneto (1)
TRIAD – Sponsored Research (0)
Burke Insitute (3)
University of Miami (1)
University of San Antonio Texas (1)
TRIAD – Therapeutics (1)
Applied Therapeutics (7)
Pharnext (8)
Rarebase (3)
Types of CMT (0)
CMT Type – CMT1A (15)
CMT Type – CMT2A (6)
CMT Type – CMT2C (3)
CMT Type – CMT4A GDAP1 (2)
CMT Type – GAN (4)
CMT Type – HNPP (2)
CMT Type – MTRFR-C12orf65 (3)
CMT Type – SORD Deficiency (5)
Upcoming Events (2)
Ways to Give (3)